do you have to taper off semaglutide Weight Loss Maintained With Slow of Semaglutide Maintenance: Taper Off Without

ALP mutations Subnormal ALP levels have been reported in patients with hypophosphatasia (HPP), a rare inherited systemic metabolic disease caused by mutations of the tissue-nonspecific ALP ( TNSALP ) gene

dose adjustment of concomitant medications may be necessary Injection site reactions mild redness, itching, or swelling at the injection site Headache generally mild and self-limiting Rare but serious adverse effects that require immediate medical attention include: Pancreatitis severe, persistent abdominal pain radiating to the back, often accompanied by vomiting Gallbladder problems right upper abdominal pain, particularly after eating fatty meals Diabetic retinopathy complications worsening of existing diabetic eye disease, particularly with rapid glycaemic improvement Acute kidney injury usually secondary to severe dehydration from gastrointestinal effects If you experience any side effects, talk to your doctor, pharmacist or nurse

The recent conclusion of major phase 3 trials for the oral glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide represents another notable setback in this endeavor (Scragg et al., 2025)

Summary: So which medication is best